|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Department of Medical Biochemistry, University of the Witwatersrand Medical School, South Africa
2 From the Department of Medicine, Hillbrow Hospital, University of the Witwatersrand Medical School, South Africa
3 From the Institute of Bio-Statistics of the Medical Research Council of South Africa, Johannesburg
Background: Pneumonia continues to be a major cause of disease and death among patients worldwide. Aspects of the host response to infection, such as the release of cytokines, may be contributing to the persistent morbidity and mortality.
Methods: Plasma levels of cytokines interleukin (IL)-1β, IL-6, and tumor necrosis factor alpha (TNF-
) were measured in critically ill patients with pneumonia (ICUP; n=12) and less severely ill patients with pneumonia (NONICUP; n=8), and in 2 additional control groups of patients, viz, severely ill postoperative patients without evidence of infection (POSTOP; n=11) and less severely ill patients with nonpneumonia infections (NONP; n=9). All four groups of patients were studied in a multivariate one-way analysis of variance using the parameter vector: plasma IL-1β, IL-6, TNF-
, systolic blood pressure, diastolic blood pressure, plasma urea, creatinine, and temperature. Thereafter the significance of individual parameters were assessed by univariate analysis and pairwise comparisons.
Results: All cytokine concentrations were highest in the ICUP group. In the case of IL-1β, levels were significantly higher in the ICUP group when compared with the noninfected POSTOP group. The acute physiology and chronic health evaluation (APACHE) II scores were identical in these two groups (17±3 [SD] and 10±1, respectively, not significantly different). Intermediate levels were found in those groups with intermediate levels of infection. The IL-6 levels were not significantly different between the groups and in particular, the levels in the ICUP and POSTOP groups were similar. The TNF-
levels tended to mimic those of IL-lβ, although the significant difference found was between the ICUP and NONICUP groups which had significantly different APACHE II scores (17±3 vs 4.4±1, respectively). No association between cytokine levels and patient mortality was demonstrated.
Conclusion: Among the cytokines, IL-1β appeared to be associated with the severity of infection, IL-6 appears to reflect severity of stress whether of infection or noninfective origin, and TNF-
may be a marker of severity of pneumonia.
Key Words: cytokine interleukin-1 interleukin-6 pneumonia tumor necrosis factor
Submitted on December 28, 1993
Accepted on August 17, 1994
This article has been cited by other articles:
![]() |
M. A. Martinez-Garcia, J.-J. Soler-Cataluna, M. Perpina-Tordera, P. Roman-Sanchez, and J. Soriano Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis Bronchiectasis Chest, November 1, 2007; 132(5): 1565 - 1572. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Confalonieri, R. Urbino, A. Potena, M. Piattella, P. Parigi, G. Puccio, R. Della Porta, C. Giorgio, F. Blasi, R. Umberger, et al. Hydrocortisone Infusion for Severe Community-acquired Pneumonia: A Preliminary Randomized Study Am. J. Respir. Crit. Care Med., February 1, 2005; 171(3): 242 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Benito, A. Moreno, X. Filella, J. M. Miro, J. Gonzalez, T. Pumarola, M. E. Valls, M. Luna, F. Garcia, A. Rano, et al. Inflammatory Responses in Blood Samples of Human Immunodeficiency Virus-Infected Patients with Pulmonary Infections Clin. Vaccine Immunol., May 1, 2004; 11(3): 608 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Antunes, S.A. Evans, J.L. Lordan, and A.J. Frew Systemic cytokine levels in community-acquired pneumonia and their association with disease severity Eur. Respir. J., October 1, 2002; 20(4): 990 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Angus, T. J. Marrie, D. S. Obrosky, G. Clermont, T. T. Dremsizov, C. Coley, M. J. Fine, D. E. Singer, and W. N. Kapoor Severe Community-acquired Pneumonia: Use of Intensive Care Services and Evaluation of American and British Thoracic Society Diagnostic Criteria Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 717 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
U K Kolling, F Hansen, J Braun, L Rink, H A Katus, and K Dalhoff Leucocyte response and anti-inflammatory cytokines in community acquired pneumonia Thorax, February 1, 2001; 56(2): 121 - 125. [Abstract] [Full Text] |
||||
![]() |
M. Duong, M. Simard, Y. Bergeron, and M. G. Bergeron Kinetic Study of the Inflammatory Response in Streptococcus pneumoniae Experimental Pneumonia Treated with the Ketolide HMR 3004 Antimicrob. Agents Chemother., January 1, 2001; 45(1): 252 - 262. [Abstract] [Full Text] |
||||
![]() |
M. J. Manary, K. E. Yarasheski, C. A. Hart, and R. L. Broadhead Plasma Urea Appearance Rate Is Lower When Children with Kwashiorkor and Infection Are Fed Egg White-Tryptophan Rather than Milk Protein J. Nutr., January 1, 2000; 130(2): 183 - 188. [Abstract] [Full Text] |
||||
![]() |
J R Catterall Lung infections bullet 5: Streptococcus pneumoniae Thorax, October 1, 1999; 54(10): 929 - 937. [Full Text] |
||||
![]() |
T. Matsumoto, K. Tateda, S. Miyazaki, N. Furuya, A. Ohno, Y. Ishii, Y. Hirakata, and K. Yamaguchi Effect of Antiflagellar Human Monoclonal Antibody on Gut-Derived Pseudomonas aeruginosa Sepsis in Mice Clin. Vaccine Immunol., July 1, 1999; 6(4): 537 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Glynn, R Coakley, I Kilgallen, N Murphy, and S O'Neill Circulating interleukin 6 and interleukin 10 in community acquired pneumonia Thorax, January 1, 1999; 54(1): 51 - 55. [Abstract] [Full Text] |
||||
![]() |
M. Duong, M. Simard, Y. Bergeron, N. Ouellet, M. Côté-Richer, and M. G. Bergeron Immunomodulating Effects of HMR 3004 on Pulmonary Inflammation Caused by Heat-Killed Streptococcus pneumoniae in Mice Antimicrob. Agents Chemother., December 1, 1998; 42(12): 3309 - 3312. [Abstract] [Full Text] |
||||
![]() |
Y. Bergeron, N. Ouellet, A.-M. Deslauriers, M. Simard, M. Olivier, and M. G. Bergeron Reduction by Cefodizime of the Pulmonary Inflammatory Response Induced by Heat-Killed Streptococcus pneumoniae in Mice Antimicrob. Agents Chemother., October 1, 1998; 42(10): 2527 - 2533. [Abstract] [Full Text] |
||||
![]() |
L. S. NIXON, B. YUNG, S. C. BELL, J. STUART ELBORN, and D. J. SHALE Circulating Immunoreactive Interleukin-6 in Cystic Fibrosis Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1764 - 1769. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Bergeron, N. Ouellet, A.-M. Deslauriers, M. Simard, M. Olivier, and M. G. Bergeron Cytokine Kinetics and Other Host Factors in Response to Pneumococcal Pulmonary Infection in Mice Infect. Immun., March 1, 1998; 66(3): 912 - 922. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |